Malaria in sub-Saharan Africa-a continuing risk for international travellers

Ralph Huits¹, Davidson H Hamer^{2

3

4

5}

Affiliations

¹ Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella, Verona, Italy.
² Department of Global Health, Boston University School of Public Health, Boston, MA 02118, USA.
³ Section of Infectious Diseases, Boston University School of Medicine, Boston, MA 02118, USA.
⁴ National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118, USA.
⁵ Center for Emerging Infectious Disease Research and Policy, Boston University, Boston, MA 02118, USA.

Ralph Huits et al. J Travel Med. 2022.

. 2022 Jul 14;29(4):taac078.

doi: 10.1093/jtm/taac078.

Ralph Huits¹, Davidson H Hamer^{2

3

4

5}

¹ Department of Infectious Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella, Verona, Italy.
² Department of Global Health, Boston University School of Public Health, Boston, MA 02118, USA.
³ Section of Infectious Diseases, Boston University School of Medicine, Boston, MA 02118, USA.
⁴ National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA 02118, USA.
⁵ Center for Emerging Infectious Disease Research and Policy, Boston University, Boston, MA 02118, USA.

No abstract available

Keywords: Africa; Malaria; chemoprophylaxis; diagnostics; equity of access; risk; treatment.

MeSH terms